Showing results (211-220 of 527) with videos related to
Sort By:
Pageof 53
Movement Disorders : Official Journal of the Movement Disorder Society|September 17, 2004
Lack of mutations in DJ-1 in a cohort of Taiwanese ethnic Chinese with early-onset parkinsonismPaul J Lockhart, Rebecca Bounds, Mary Hulihan, et al.Neurobiology of Disease|November 17, 2019
Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's diseaseFabian Maass, Bernhard Michalke, Desiree Willkommen, et al.Diagnostics (Basel, Switzerland)|May 28, 2022
Baseline Cerebrospinal Fluid α-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive DeclineAnna Emdina, Peter Hermann, Daniela Varges, et al.Analytical and Bioanalytical Chemistry|July 13, 2022
Studying the Parkinson's disease metabolome and exposome in biological samples through different analytical and cheminformatics approaches: a pilot studyBegoña Talavera Andújar, Dagny Aurich, Velma T E Aho, et al.NPJ Parkinson'S Disease|March 20, 2021
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylaseAnouke van Rumund, Lukas Pavelka, Rianne A J Esselink, et al.Biomarkers in Medicine|March 30, 2017
The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's diseaseNaomi P Visanji, Brit Mollenhauer, Thomas G Beach, et al.Dementia and Geriatric Cognitive Disorders|April 2, 2005
Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob diseaseLukas Cepek, Petra Steinacker, Brit Mollenhauer, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 8, 2017
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohortTanya Simuni, Chelsea Caspell-Garcia, Christopher S Coffey, et al.Neuro-Oncology|April 12, 2012
MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activityNadiya M Teplyuk, Brit Mollenhauer, Galina Gabriely, et al.Frontiers in Pharmacology|April 11, 2022
Neuroinflammation Upregulated Neuronal Toll-Like Receptors 2 and 4 to Drive Synucleinopathy in NeurodegenerationLucia Yi-Ru Chung, Yi-Ting Lin, Chi Liu, et al.Pageof 53